FDA sets deadline for morning-after pill
The FDA will make a decision on switching Barr Laboratories’ emergency contraceptive to OTC status by Sept. 1st.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.